Aidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling Sennosides tablets because they may have been mislabeled as other medications. The recall covers distribution in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, which aligns with the criteria for a Moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling 1,400 tablets of Sennosides, 8.6 mg, Over The Counter. The recall was initiated because the product may have been mislabeled as Fexofenadine HCL, 180 mg, Trimethobenzamide HCL, 300 mg, or Loratadine, 10 mg.
The affected Sennosides tablets have the following pedigree and expiration codes: Pedigree AD62992_14 with an expiration date of 5/23/2014; Pedigree W002979 with an expiration date of 6/11/2014; and Pedigree W003256 with an expiration date of 6/17/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication for the specific pedigree and expiration codes listed above. If the product matches the recalled items, they should stop using it and contact their pharmacist or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- SENNOSIDES, Tablet, 8.6 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00182109301.
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 1,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- SENNOSIDES
- Tablet
- 8.6 mg has the following codes: Pedigree: AD62992_14
- EXP: 5/23/2014
- Pedigree: W002979
- EXP: 6/11/2014
- Pedigree: W003256
- EXP: 6/17/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nebivolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateSennosides Tablets Recalled for Potential Labeling Mixup with Saccharomyces Boulardii
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Trazodone Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Caffeine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls 40 mg Pantoprazole Sodium Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Olanzapine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- HighFDA Recalls Famotidine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22